It has been reported that BEX2 is a binding partner of LMO2, a T-cell oncogene with recurrent chromosomal translocations in T-cell acute leukemias [9], and enhances the transcriptional activity of LMO2-NSCL2 complex [10]. This evidence concerns the gene LMO2 and T-cell acute lymphoblastic leukemia.